Patents by Inventor BRAD J. DOUGLASS

BRAD J. DOUGLASS has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Bolus dose of hydroxycitric acid with glycerol
    Patent number: 11219610
    Abstract: A method of delivering a daily dose of hydroxycitric acid in the form of a salt as a single bolus that is as effective or more so than the same amount of active delivered via two or three administrations (b.i.d. or t.i.d.) using current delivery modalities. The method reduces the rate of occurrence of common adverse events with hydroxycitric acid salts, and reduces the occurrence of reverse effects on diets high in fat and/or alcohol. The method improves the uptake of the active compound thereby reducing the dose required.
    Type: Grant
    Filed: March 11, 2020
    Date of Patent: January 11, 2022
    Assignee: GLYKON TECHNOLOGIES GROUP, LLC
    Inventors: Dallas L. Clouatre, Daniel E. Clouatre, Brad J. Douglass
  • Bolus Dose of Hydroxycitric Acid with Glycerol
    Publication number: 20200206171
    Abstract: A method of delivering a daily dose of hydroxycitric acid in the form of a salt as a single bolus that is as effective or more so than the same amount of active delivered via two or three administrations (b.i.d. or t.i.d.) using current delivery modalities. The method reduces the rate of occurrence of common adverse events with hydroxycitric acid salts, and reduces the occurrence of reverse effects on diets high in fat and/or alcohol. The method improves the uptake of the active compound thereby reducing the dose required.
    Type: Application
    Filed: March 11, 2020
    Publication date: July 2, 2020
    Applicant: Glykon Technologies Group, LLC
    Inventors: Dallas L. Clouatre, Daniel E. Clouatre, Brad J. Douglass
  • Bolus dose of hydroxycitric acid with glycerol
    Patent number: 10624868
    Abstract: A method of delivering a daily dose of hydroxycitric acid in the form of a salt as a single bolus that is as effective or more so than the same amount of active delivered via two or three administrations (b.i.d. or t.i.d.) using current delivery modalities. The method reduces the rate of occurrence of common adverse events with hydroxycitric acid salts, and reduces the occurrence of reverse effects on diets high in fat and/or alcohol. The method improves the uptake of the active compound thereby reducing the dose required.
    Type: Grant
    Filed: June 25, 2019
    Date of Patent: April 21, 2020
    Assignee: GLYKON TECHNOLOGIES GROUP, LLC
    Inventors: Dallas L. Clouatre, Daniel E. Clouatre, Brad J. Douglass
  • BOLUS DOSE OF HYDROXYCITRIC ACID WITH GLYCEROL
    Publication number: 20190314310
    Abstract: A method of delivering a daily dose of hydroxycitric acid in the form of a salt as a single bolus that is as effective or more so than the same amount of active delivered via two or three administrations (b.i.d. or t.i.d.) using current delivery modalities. The method reduces the rate of occurrence of common adverse events with hydroxycitric acid salts, and reduces the occurrence of reverse effects on diets high in fat and/or alcohol. The method improves the uptake of the active compound thereby reducing the dose required.
    Type: Application
    Filed: June 25, 2019
    Publication date: October 17, 2019
    Inventors: Dallas L. CLOUATRE, Daniel E. CLOUATRE, Brad J. DOUGLASS
  • Bolus dose of hydroxycitric acid with glycerol
    Patent number: 10376483
    Abstract: A method of delivering a daily dose of hydroxycitric acid in the form of a salt as a single bolus that is as effective or more so than the same amount of active delivered via two or three administrations (b.i.d. or t.i.d.) using current delivery modalities. The method reduces the rate of occurrence of common adverse events with hydroxycitric acid salts, and reduces the occurrence of reverse effects on diets high in fat and/or alcohol. The method improves the uptake of the active compound thereby reducing the dose required.
    Type: Grant
    Filed: May 9, 2018
    Date of Patent: August 13, 2019
    Assignee: Glykon Technologies Group, LLC
    Inventors: Dallas L. Clouatre, Daniel E. Clouatre, Brad J. Douglass
  • BOLUS DOSE OF HYDROXYCITRIC ACID WITH GLYCEROL
    Publication number: 20180256527
    Abstract: A method of delivering a daily dose of hydroxycitric acid in the form of a salt as a single bolus that is as effective or more so than the same amount of active delivered via two or three administrations (b.i.d. or t.i.d.) using current delivery modalities. The method reduces the rate of occurrence of common adverse events with hydroxycitric acid salts, and reduces the occurrence of reverse effects on diets high in fat and/or alcohol. The method improves the uptake of the active compound thereby reducing the dose required.
    Type: Application
    Filed: May 9, 2018
    Publication date: September 13, 2018
    Applicant: Glykon Technologies Group, LLC
    Inventors: Dallas L. CLOUATRE, Daniel E. CLOUATRE, Brad J. DOUGLASS
  • Bolus dose of hydroxycitric acid with glycerol
    Patent number: 9993448
    Abstract: A method of delivering a daily dose of hydroxycitric acid in the form of a salt as a single bolus that is as effective or more so than the same amount of active delivered via two or three administrations (b.i.d. or t.i.d.) using current delivery modalities. The method reduces the rate of occurrence of common adverse events with hydroxycitric acid salts, and reduces the occurrence of reverse effects on diets high in fat and/or alcohol. The method improves the uptake of the active compound thereby reducing the dose required.
    Type: Grant
    Filed: September 11, 2017
    Date of Patent: June 12, 2018
    Assignee: GLYKON TECHNOLOGIES GROUP, LLC
    Inventors: Dallas L. Clouatre, Daniel E. Clouatre, Brad J. Douglass
  • BOLUS DOSE OF HYDROXYCITRIC ACID WITH GLYCEROL
    Publication number: 20170368008
    Abstract: A method of delivering a daily dose of hydroxycitric acid in the form of a salt as a single bolus that is as effective or more so than the same amount of active delivered via two or three administrations (b.i.d. or t.i.d.) using current delivery modalities. The method reduces the rate of occurrence of common adverse events with hydroxycitric acid salts, and reduces the occurrence of reverse effects on diets high in fat and/or alcohol. The method improves the uptake of the active compound thereby reducing the dose required.
    Type: Application
    Filed: September 11, 2017
    Publication date: December 28, 2017
    Applicant: GLYKON TECHNOLOGIES GROUP, LLC
    Inventors: Dallas L. CLOUATRE, Daniel E. CLOUATRE, Brad J. DOUGLASS
  • Bolus dose of hydroxycitric acid with glycerol
    Patent number: 9789076
    Abstract: A method of delivering a daily dose of hydroxycitric acid in the form of a salt as a single bolus that is as effective or more so than the same amount of active delivered via two or three administrations (b.i.d. or t.i.d.) using current delivery modalities. The method reduces the rate of occurrence of common adverse events with hydroxycitric acid salts, and reduces the occurrence of reverse effects on diets high in fat and/or alcohol. The method improves the uptake of the active compound thereby reducing the dose required.
    Type: Grant
    Filed: February 4, 2015
    Date of Patent: October 17, 2017
    Assignee: GLYKON TECHNOLOGIES GROUP, LLC
    Inventors: Dallas L. Clouatre, Daniel E. Clouatre, Brad J. Douglass
  • BOLUS DOSE OF HYDROXYCITRIC ACID WITH GLYCEROL
    Publication number: 20160136117
    Abstract: A method of delivering a daily dose of hydroxycitric acid in the form of a salt as a single bolus that is as effective or more so than the same amount of active delivered via two or three administrations (b.i.d. or t.i.d.) using current delivery modalities. The method reduces the rate of occurrence of common adverse events with hydroxycitric acid salts, and reduces the occurrence of reverse effects on diets high in fat and/or alcohol. The method improves the uptake of the active compound thereby reducing the dose required.
    Type: Application
    Filed: February 4, 2015
    Publication date: May 19, 2016
    Inventors: DALLAS L. CLOUATRE, DANIEL E. CLOUATRE, BRAD J. DOUGLASS